$4.84
Today
as of Jul 22, 16:47 ET
Last 30 days
Recent Press Releases & News
Cingulate Inc. (NASDAQ: CING) Added to Russell 3000E®
Cingulate Issued First U.S. Patent for Lead ADHD Asset CTx-1301
Stonegate Capital Partners Updates Coverage on Cingulate Inc. (CING) 1Q26
Overview
52-week range
$3.16
$12
19% of range
Avg surprise (last 3)
-38.7%
Avg reaction (last 2)
-3.5%
50% positive
Latest IV / EM
108%
EM ±24.8% · $5 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Thu May 14, 2026 | Mar/2026 | $-0.95 | $-0.53 | -79.2% | +8.7% | -10.8% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-1.35 | — | — | — | — | financials |
| Tue Aug 19, 2025 | Jun/2025 | $-1.09 | $-0.82 | -32.9% | — | — | earnings |
| Thu May 8, 2025 | Mar/2025 | $-1.04 | $1.00 | -4.0% | — | +3.8% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-2.34 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-5.47 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-7.21 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-72.60 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-6.79 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Tue Aug 18, 2026 | Jun/2026 | OTHER | -$0.63 | -$1.09 | +42.2% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-8M | — | $-6M | $-5M | $-4M | — | $-3M | $-3M |
| Net income | $-9M | — | $-7M | $-5M | $-4M | — | $-4M | $-3M |
| EPS (diluted) | $-0.95 | — | $-1.35 | $-1.09 | $-1.06 | — | $-2.34 | $-5.47 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $26M | $11M | $6M | $9M | $10M | $12M | $10M | $380,928 |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $28M | $12M | $7M | $10M | $11M | $13M | $11M | $3M |
| Total assets | $31M | $15M | $11M | $13M | $12M | $15M | $14M | $5M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $12M | $13M | $7M | $8M | $7M | $7M | $2M | $2M |
| Total equity | $19M | $3M | $3M | $6M | $6M | $7M | $12M | $3M |